Study ID: BDP-AR-305
Study Title
- Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Female, Maleergies
Teva Identifier
- BDP-AR-305
ClinicalTrials.gov Identifier
- NCT01307319
Study Status
- Completed
Trial Condition(s)
- Seasonal Female, Maleergic Rhinitis | SAR
Interventions
- Drug: BDP HFA | Drug: Placebo nasal aerosol
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 6 Years to 11 Years
Trial Duration
- 03/01/2011 - 08/01/2011
Phase
- Phase 3
Study Type
Interventional
